Collective Health and Nooms joint offering delivers cost savings, flexible cost-sharing options, and reliable access and efficient fulfillment for GLP-1 medications San Francisco, Calif., March 26, 2025 Collective Health, a leader in employee health benefits, and digital healthcare leader Nooms enterprise division, Noom Health, have partnered to deliver Collective Health + Noom Med with Smart Rx , an enterprise weight management solution with an integrated GLP-1 drug program that is available to Collective Health employer customers
Emerging data in clinical and preclinical studies suggests the adverse and efficacious effects of these pharmacotherapies can be dissociated, and that GIPR agonism improves the GI AE profile of GLP-1R and dual incretin receptor agonists
All GLP-1 medications require proper evaluation, prescribing, and monitoring by licensed healthcare professionals
In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues